Stock Earnings

Question 1

Quels sont les états financiers clés de Alibaba Health Information Technology Ltd ?

Accepted Answer

Selon le dernier état financier (Form-10K), Alibaba Health Information Technology Ltd a un total d'actifs de $21,178, un bénéfice net profit de $1,432

Question 2

Quels sont les ratios financiers clés pour ALBBY ?

Accepted Answer

Le ratio de liquidité de Alibaba Health Information Technology Ltd est 4.35, la marge nette est 4.68, les ventes par action sont de $1.89.

Question 3

Comment les revenus de Alibaba Health Information Technology Ltd sont-ils répartis par segment ou géographie ?

Accepted Answer

Alibaba Health Information Technology Ltd largest revenue segment is Pharmaceutical Direct Sales, at a revenue of 28,204,711,439 in the most earnings release.For geography, China is the primary market for Alibaba Health Information Technology Ltd, at a revenue of 33,034,838,530.

Question 4

Alibaba Health Information Technology Ltd est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, Alibaba Health Information Technology Ltd a un bénéfice net profit de $1,432

Question 5

Alibaba Health Information Technology Ltd a-t-elle des passifs ?

Accepted Answer

yes, Alibaba Health Information Technology Ltd a un passif de 4,866

Question 6

Combien d'actions en circulation Alibaba Health Information Technology Ltd a-t-elle ?

Accepted Answer

Alibaba Health Information Technology Ltd a un total d'actions en circulation de 16,076.36

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	30,598	30,598	27,026	26,763	20,577	15,518
Revenue Growth (YoY)	13%	13%	1%	30%	33%	62%
Cost of Revenue	23,166	23,166	21,131	21,061	16,469	11,901
Gross Profit	7,432	7,432	5,895	5,701	4,107	3,617
Selling, General & Admin	2,683	2,672	2,136	2,161	2,376	1,529
Research & Development	720	720	705	677	728	423
Operating Expenses	6,087	5,834	5,169	5,670	5,106	3,567
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1,559	1,559	939	550	-252	401
Income Tax Expense	127	127	56	14	13	58
Net Income	1,432	1,432	883	535	-265	348
Net Income Growth	62%	62%	65%	-302%	-176%	-5,900%
Shares Outstanding (Diluted)	16,175.08	16,135.8	14,090.69	13,541.57	13,482.63	13,326.52
Shares Change (YoY)	11%	15%	4%	0%	1%	12%
EPS (Diluted)	0.08	0.08	0.06	0.03	-0.01	0.02
EPS Growth	41%	42%	57.99%	-301%	-175%	-4,467%
Free Cash Flow	1,376	1,376	1,057	249	409	991
Free Cash Flow Per Share	0.08	0.08	0.07	0.01	0.03	0.07
Gross Margin	24.28%	24.28%	21.81%	21.3%	19.95%	23.3%
Operating Margin	4.39%	5.21%	2.68%	0.11%	-4.85%	0.32%
Profit Margin	4.68%	4.68%	3.26%	1.99%	-1.28%	2.24%
Free Cash Flow Margin	4.49%	4.49%	3.91%	0.93%	1.98%	6.38%
EBITDA	1,401	1,654	778	94	-938	83
EBITDA Margin	4.57%	5.4%	2.87%	0.35%	-4.55%	0.53%
D&A For EBITDA	57	57	53	63	60	33
EBIT	1,344	1,597	725	31	-998	50
EBIT Margin	4.39%	5.21%	2.68%	0.11%	-4.85%	0.32%
Effective Tax Rate	8.14%	8.14%	5.96%	2.54%	-5.15%	14.46%

Alibaba Health Information Technology Ltd (ALBBY) Price

ALBBY Stock Price Chart

ALBBY Income

Follow-Up Questions